Skip to main content

Table 1 Patient and treatment characteristics

From: Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer – a retrospective single center analysis

 

n

%

Age

median

50

range

18-71

Gender

  

male

37

76

female

12

24

T stage

1

7

14

2a

5

10

2b

19

39

3

8

16

4

10

20

N stage

0

10

20

1

12

24

2

21

43

3a

1

2

3b

5

10

Clinical stage

I

2

4

IIa

1

2

IIb

11

22

III

21

43

IVa

8

16

IVb

6

12

Histology

I

3

6

II

6

12

III

40

82

Concurrent CHT

cis weekly

31

63

carbo weekly

2

4

cis/5-FU

11

22

carbo/5-FU

4

8

5-FU

1

2

  1. Age [years], T, N and clinical stage according to 6th edition of the International Union against Cancer (UICC) TNM classification, histology according to world health organisation (WHO) classification, Cis: Cisplatin, Carbo: Carboplatin, 5-FU: 5-Fluorouracil, n: number of patients,%: percentage of the entire cohort, CHT: concurrent chemotherapy.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us